⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
Lilly announces three acquisitions to build infectious disease portfolio USA - English USA - English
prnewswire.com
LLY
LimmaTech Biologics to be Acquired by Lilly for Next-generation Vaccines Against Common Bacterial Infections
businesswire.com
LLY
CGRP Inhibitors Market to Reach US$12.5 Bn by 2033 Expands with Rising Migraine Awareness and Advanced Targeted Therapies - Persistence Market Research
prnewswire.com
AMGN
LLY
TEVA
PFE
ABBV
A single dose of Lilly's PCSK9 base editor, VERVE-102, reduced PCSK9 by up to 88% and LDL-C by up to 62%, with durable effects supporting its potential as a one-time treatment for hypercholesterolemia
prnewswire.com
LLY
Harvest High Income Shares ETFs Announces May 2026 Distributions
businesswire.com
LLY
AMZN
MSFT
NVDA
COIN
PLTR
TSLA
META
AMD
AVGO
COST
GOOGL
NFLX
AAPL
CRWD
JNJ
ORCL
CME
BCE
ENB
SHOP
SU
TEL
FNB Harvest d'actions à revenu élevé annonce les distributions de mai 2026
businesswire.com
AMZN
MSFT
NVDA
LLY
MSTR
PLTR
TSLA
META
AMD
AVGO
COIN
COST
GOOGL
NFLX
AAPL
SOFI
BLKB
CRWD
JNJ
ORCL
ENB
SHOP
SU
TEL
Lilly to showcase oncology portfolio across tumor types and treatment modalities at the 2026 American Society of Clinical Oncology Annual Meeting
prnewswire.com
LLY
GLP-1 Receptor Agonist Market Report 2026
globenewswire.com
NVO
SNY
LLY
Wellness Clinic Prana IV Therapy Discusses Nutritional Gaps Linked to GLP-1 Weight Loss Drugs
prnewswire.com
NVO
LLY
Peptide-Based Health Industry Positioned for Explosive Long-Term Growth Across Global Wellness Markets
globenewswire.com
MMA
NVO
HIMS
LLY